• H-89: cAMP-Dependent Protein Kinase Inhibitor in Bone Resear

  2026-07-08

  H-89 enables precise modulation of cAMP signaling, empowering researchers to dissect protein kinase A–driven pathways in osteogenesis, metabolism, and apoptosis. Discover optimized workflows, real-world troubleshooting, and how recent findings on Wnt-induced O-GlcNAcylation reshape applied assay strategies.

• LY2228820: Applied p38 MAP Kinase Inhibitor Workflows & Tips

  2026-07-08

  LY2228820 stands out as a highly selective, ATP-competitive p38 MAP kinase inhibitor, enabling precision in anti-inflammatory and cancer research. This guide delivers stepwise protocols, practical troubleshooting, and expert workflow enhancements tailored to maximize the compound's impact in the lab.

• Cy3 NHS ester (non-sulfonated): Technical Guide and Best Pra

  2026-07-07

  Cy3 NHS ester (non-sulfonated) addresses the need for high-sensitivity fluorescent labeling of biomolecules in protocols compatible with organic co-solvents. It is optimal for labeling proteins, peptides, and oligonucleotides where aqueous solubility is not required. This product is not suitable for water-only workflows or for labeling delicate proteins sensitive to organic solvents.

• Autophagy Modulates Resveratrol-Induced Apoptosis in RCC Cel

  2026-07-07

  This study reveals that autophagy acts as a protective mechanism against resveratrol-induced apoptosis in renal cell carcinoma (RCC) 786-O cells. By delineating the interplay between ROS, caspase-3 activation, and autophagic signaling, the research provides new insights into potential combinatorial strategies to enhance anticancer effects in RCC.

• T0070907: Applied PPARγ Antagonist Strategies for Cell Signa

  2026-07-06

  T0070907 stands out as a precision tool for dissecting PPARγ-driven pathways, enabling researchers to modulate adipogenesis and inflammation with high specificity. This guide translates bench-proven protocols and troubleshooting strategies into actionable workflows, linking the latest mechanistic insights to advanced cellular modeling.

• EdU Imaging Kits (Cy5): High-Sensitivity S-Phase Detection W

  2026-07-06

  EdU Imaging Kits (Cy5) redefine cell proliferation analysis by leveraging click chemistry for artifact-free, high-sensitivity S-phase DNA synthesis measurement. Streamlined protocols and robust fluorescence readout make these kits a top choice for both microscopy and flow cytometry workflows, particularly in applications where DNA integrity and morphology matter most.

• Cy3 NHS ester (non-sulfonated): Technical Guidance and Proto

  2026-07-05

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides via amino group modification using organic co-solvents, making it well-suited for workflows tolerant to DMSO or DMF. It is not recommended for strictly aqueous protocols or labeling water-sensitive proteins due to its poor water solubility and lack of sulfonation. This article details actionable parameters and troubleshooting for optimized use in biomedical imaging applications.

• Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-07-04

  The Caspase-3 Fluorometric Assay Kit empowers researchers with rapid, quantitative assessment of apoptosis via DEVD-dependent caspase activity. Its streamlined workflow and sensitivity make it indispensable for studies investigating cell death pathways and therapeutic interventions in cancer and neurodegeneration.

• Hyperthermia & Cisplatin Synergize via Caspase-8 in Cancer C

  2026-07-03

  This study uncovers how combining hyperthermia with cisplatin chemotherapy enhances cancer cell death by promoting caspase-8 accumulation and activation, which triggers both apoptosis and pyroptosis. These mechanistic insights reveal new strategies to optimize combinatorial cancer therapies targeting cysteine-dependent aspartate-directed proteases.

• PP2A-Regulated Autophagy Drives Drug Resistance in Candida B

  2026-07-03

  This study reveals that protein phosphatase 2A (PP2A) modulates autophagy through ATG protein phosphorylation, enhancing both biofilm formation and drug resistance in Candida albicans. These findings highlight autophagy as a promising regulatory target for overcoming antifungal resistance in biofilm-associated infections.

• Octyl-α-ketoglutarate: Precision Prolyl Hydroxylase Substrat

  2026-07-02

  Octyl-α-ketoglutarate unlocks robust, cell-permeable delivery of α-KG for high-fidelity modulation of HIF-1α stability in hypoxia signaling assays. Its unique stability and permeability profile empower metabolic and cancer researchers to dissect TCA cycle dysfunction and IDH mutation effects with clarity that standard α-KG cannot match.

• Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-07-02

  Unlock sensitive, rapid detection of caspase-3 activity in apoptosis research with the Caspase-3 Fluorometric Assay Kit. This workflow-driven guide explores applied use-cases, troubleshooting strategies, and leverages insights from ferroptosis-apoptosis crosstalk studies for advanced experimental design.

• Molecular Mechanisms of Aneugenicity: Insights from 27 Chemi

  2026-07-01

  The referenced study establishes a robust assay for identifying the molecular mechanisms underlying chemical-induced aneugenicity, distinguishing between tubulin stabilization, destabilization, and mitotic kinase inhibition in TK6 cells. Its machine learning-based approach offers a reproducible strategy for mechanistic genotoxicity assessment, with implications for drug discovery and cellular pathway research.

• CSRP2 Regulates Glioma Progression via PRC1 and PDGFRA Pathw

  2026-07-01

  This study reveals that CSRP2 promotes glioma aggressiveness by epigenetically regulating PDGFRA transcription through interactions with Polycomb repressive complex 1 components, impacting the PI3K/AKT pathway. These findings highlight a novel regulatory axis in mesenchymal glioblastoma and suggest new biomarker and mechanistic targets for brain tumor research.

• Mechanistic Insights into Gepotidacin and S. aureus Gyrase I

  2026-06-30

  Gibson et al. provide a detailed mechanistic and structural analysis of gepotidacin, a novel bacterial topoisomerase inhibitor, revealing a unique mode of inhibition against Staphylococcus aureus DNA gyrase. The findings clarify distinctions from fluoroquinolones and have important implications for antibiotic resistance research and future drug design.

16303 records 1/1087 page Next 12345 下5页 Last page